Death of Miguel Granja MD

The Latin American Society of Interventional Cardiology (SOLACI) regrets to inform the deceased of Miguel Granja MD, renowned and prestigious pediatric interventional cardiologist.

Dr. Granja was instructor of many physicians, both Argentinian and Latin American, which today practice pediatric interventionism and adult congenital heart disease.

He was chief and creator of the Hemodynamics Service at Children’s Hospital Dr. Pedro de Elizalde, Head of the Pediatric Hemodynamics at Hospital Italiano, Founding Member of the Latin American Society of Interventional Cardiology and former Director of the Pediatric Committee of the Argentine College of Interventional Cardioangiologists.

SOLACI mourns the passing of this teacher and friend.

SOLACI

More articles by this author

Fellow’s Corner – Case 2: Acute Myocardial Infarction Due to Simultaneous Occlusion of Two Coronary Arteries

Share your experience. Learn from experts. Grow as an interventional cardiologist. A new edition of the Fellow’s Corner is here, an academic exchange space designed...

Institutional Statement: SOLACI Expresses Its Solidarity with the People of Venezuela

The Latin American Society of Interventional Cardiology (SOLACI) expresses its deepest sorrow over the consequences of the earthquake that has affected Venezuela. We stand in...

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

The Latin American Society of Interventional Cardiology (SOLACI) proudly grants its scientific endorsement to the V International Course on Cardiovascular Interventionism, an important academic...

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

The call for applications to participate in the Young Interventional Cardiologists Competition at the Guatemala 2026 Regional Sessions is now open. The event will...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Coronary artery disease progression after transcatheter aortic valve replacement: quantitative coronary angiography and Quantitative Flow Ratio analysis

The coexistence of coronary artery disease and severe aortic stenosis is common among patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of...